Understand the signals behind social masking. NDMS synchronizes facial video and vocal streams to estimate moment-to-moment social masking effort and return interpretable risk signals—designed to empower emotional self-regulation and reduce fatigue, not perform surveillance or diagnosis.
Cross-Modal Status: High Mismatch (Smile Pose vs Prosodic Monotone / Pitch Flattening)
Estimated Latent / Suppressed Signal
Cognitive Load & Latent Exhaustion
PROBABILISTIC OUTPUT — HUMAN CONTEXT REQUIRED
Temporal Alignment Segments:
Illustrative Notice: Displayed scores, uncertainty values, signal qualities, emotion indicators, and heatmaps are simulated illustrative examples and do not represent validated NDMS outputs.
IP StatusPatent Application Filed (ISA Review)
ArchitectureMultimodal System Defined
PrototypeUnder Active Development
ValidationProspective Validation Planned
Canonical Product Progression
From detection to self-directed emotional regulation.
Social masking demands continuous cognitive effort, frequently leading to fatigue, emotional overload, and neurodivergent burnout. NDMS is designed as an end-to-end neurotech pipeline that transforms subtle signal interactions into actionable self-understanding.
01DetectionSynchronized face + voice alignment
02UnderstandingCross-modal discordance & heatmap
03BiofeedbackReal-time masking risk index
04PersonalizationLongitudinal personal baseline
05Self-RegulationProactive rest & energy management
Transparent Maturity
From Invention to Product: Complete Transparency
We are committed to scientific honesty. NDMS is an ambitious, patent-backed neurotechnology platform in development, built on rigorous technical foundations.
IP Foundation
International Patent Application Filed
Application PCT/IB2025/060348 has proceeded through the WIPO PCT process with completed International Searching Authority (ISA) review. (Note: A patent application is not a granted patent or regulatory approval).
The public website is live; the complete working software prototype and dedicated NDMS validation dataset are under active development. An emotion-detection model was run separately (preprint upcoming), but is distinct from full masking validation.
Empirical validation studies are planned before launching public beta trials. Clinical and commercial partner conversations are active at early collaboration stages.
1Calibrated Masking Probability ScoreA 0–1.0 score estimating model evidence for social masking in the analyzed interval. High scores indicate stronger signal evidence, not medical diagnosis.
2Interpretable Facial Saliency HeatmapVisual overlay highlighting facial region tension (e.g. periorbital micro-expressions or jaw muscle tension) contributing to masking indicators.
3Estimated Suppressed-Emotion SignalsProbabilistic indicators of candidate latent emotional states (e.g., suppressed fatigue, internal anxiety, or cognitive strain) incongruent with outward facial pose.
4Modality Quality & Uncertainty InfoReal-time signal quality bars for face/voice streams and explicit uncertainty confidence bounds (e.g., ±0.05).
5Personalized Baseline TrajectoryLongitudinal tracking reflecting individual baseline communication styles and within-person pattern changes over time.
Core Production Modalities
Facial Video + Voice/Audio
The production runtime relies purely on standard camera and microphone feeds. No specialized hardware is required for end users.
Proprietary neurodivergent audio-visual dataset combined with longitudinal within-person baselines that adapt to individual communication styles over time.
"Translates affective science and cross-modal discordance into a rigorous, testable system with EEG physiological validation."
Clinicians & TherapistsHuman-in-the-Loop Context
"An emerging support tool providing structured session insights without replacing clinical judgment or forcing automated labels."
Investors, Business & CofoundersDefensible Neurotech Platform
"A patent-backed company in formation with a clear path from prototype to SaaS/API licensing and future SaMD medical pathways."
Get Involved
Connect with the NDMS Platform Program.
Whether you are a neurodivergent individual interested in future public beta access, a clinical researcher seeking validation pilots, a strategic partner exploring licensing, or a prospective cofounder, we welcome your engagement.